 |
|
Strategies for Use of a Limited Influenza Vaccine Supply
Sara E. Cosgrove, MD, MS;
Neil O. Fishman, MD;
Thomas R. Talbot, MD, MPH;
Keith F. Woeltje, MD, PhD;
William Schaffner, MD;
Victoria J. Fraser, MD;
Julia A. McMillan, MD;
Trish M. Perl, MD, MSc
JAMA. 2005;293:229-232.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
The drastically decreased supply of inactivated influenza vaccine for the 2004-2005 US influenza season presents a unique challenge for health care institutions. At the core of this challenge is the dual responsibility that health care institutions have to protect patients as well as the health professionals who are integral to the functioning of the institution. Many major hospitals and long-term care facilities have reduced or no supplies of inactivated influenza vaccine and have limited guidance about how to obtain additional vaccine or whether to expect redistribution from the remaining supply. Consequently, issues have arisen ranging from the appropriate allocation of vaccine to the role of the intranasal live, attenuated influenza vaccine (LAIV) within a health . . . [Full Text of this Article]Vaccination of Health Professionals
Author Affiliations: Johns Hopkins University School of Medicine, Division of Infectious Diseases, Department of Medicine, Baltimore, Md (Drs Cosgrove and Perl); University of Pennsylvania School of Medicine, Division of Infectious Diseases, Department of Medicine, Philadelphia (Dr Fishman); Vanderbilt University School of Medicine, Division of Infectious Diseases, Department of Medicine, Nashville, Tenn (Drs Talbot and Schaffner); Washington University School of Medicine, Division of Infectious Diseases, Department of Medicine, St Louis, Mo (Drs Woeltje and Fraser); Johns Hopkins University School of Medicine, Department of Pediatrics, Baltimore, Md (Dr McMillan).
|
